Tech giants such as Facebook, Google and Twitter will once again face Congress this week to testify in the Russian election meddling investigation. Daniel Ives, Chief Strategy Officer and Head of Technology Research at GBH Insights and Scott Kessler, Director of Equity Research and Analyst at CFRA join The Long and The Short to discuss which platform will be affected the most from this trial. Facebook announced a new News Feed where "meaningful content" will take priority over "relevant content." Ives says that this change could actually be good for the company in the long term. He doesn't believe it will impact publishers or user growth as much as people are afraid it will. When it comes to testifying on Capitol Hill, Kessler believes Facebook will be on the defense and take a firm stance on defending its platform. Plus, Twitter's stock spiked after Facebook announced it was changing its News Feed. Kessler thinks Twitter is the one company that hasn't answered questions from Congress regarding Russian meddling in the election. He talks about Twitter's long road to improve upon certain operations.

Share:
More In Technology
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Technological Breakthrough in Head Injury Prevention
Dr. Michael Bottlang and Dr. Steve Madey, co-founders of WaveCel, join Cheddar Innovates to share their breakthrough in hard hat design that could have ramifications for protecting against head trauma across industries.
Load More